Clinical trial
A Phase 3 Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy Incorporating a Randomized Assessment of Sodium Thiosulfate as Otoprotection for Children With Localized Disease, and Response Adapted Therapy for Patients With Metastatic Disease
NCT04478292 is registered in ClinicalTrials.gov with Shanghai Children's Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy Incorporating a Randomized Assessment of Sodium Thiosulfate as Otoprotection for Children With Localized Disease, and Response Adapted Therapy for Patients With Metastatic Disease
- Lead sponsor
- Shanghai Children's Medical Center
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- March 1, 2021
- Completion date
- September 30, 2027
- Enrollment
- 330 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.